Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/11/2025

Aspirin Therapy in Pediatric SLE Patients with Triple-Positive Antiphospholipid Antibodies

Introduction to Aspirin Therapy

  • The European League Against Rheumatism recommends low-dose aspirin for primary thromboprophylaxis in children with SLE who are triple-positive for antiphospholipid antibodies, as this profile substantially increases thrombotic risk 1
  • The American College of Rheumatology notes that low-dose aspirin may be added for primary prophylaxis in children with aPL when additional thrombotic risk factors are present 2

Risk Stratification and Aspirin Use

  • Triple-positive aPL constitutes a "high-risk aPL profile" that warrants primary thromboprophylaxis even in asymptomatic children, with the European League Against Rheumatism specifically identifying this profile as high-risk 1
  • A meta-analysis demonstrated a protective role of low-dose aspirin for primary prophylaxis against thrombosis specifically in the subgroup of aPL carriers who had SLE 1

Dosing and Administration of Aspirin

  • Low-dose aspirin 81-100 mg daily is recommended, as doses up to 150 mg have been studied but lack comparative evidence showing superiority over 100 mg daily 3

Mandatory Concurrent Therapy with Aspirin

  • Hydroxychloroquine is mandatory for all pediatric SLE patients regardless of aPL status, as it reduces disease flares and has direct protective effects against thrombosis 2
  • Hydroxychloroquine should be maintained as the cornerstone of SLE treatment alongside aspirin, according to the European League Against Rheumatism and the American College of Rheumatology 1, 2, 4

Confirmation Testing and Monitoring

  • Repeat aPL testing at 12 weeks to confirm persistent positivity, as transient positivity does not require intervention, and test for all three antibodies to accurately determine triple-positive status 2
  • Regular ophthalmologic screening for hydroxychloroquine retinal toxicity, with increased frequency after 5 years of continuous use, and ongoing assessment of SLE disease activity using SLEDAI scores 2

Important Considerations for Aspirin Therapy

  • Avoid estrogen-containing medications in female adolescents, as they increase thrombosis risk in lupus patients with antiphospholipid antibodies, according to the American College of Rheumatology and the European League Against Rheumatism 5
  • For female patients reaching childbearing age with pregnancy plans, full anticoagulation with LMWH plus aspirin will be required, as warfarin is teratogenic, and this is recommended by the American College of Rheumatology and the European League Against Rheumatism 3, 5, 2

REFERENCES

2

Management of Pediatric SLE with Low-Titer Antiphospholipid Antibodies [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

4

SLE and DVT Risk [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

5

Stroke Prevention in SLE Patients [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025